TOXINS 2024 Galdermas Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crows Feet Simultaneously
Galderma announced today positive topline results from the phase III READY3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines frown lines and lateral canthal lines crows feet either alone singlearea or simultaneously.
Source: businesswireindia.com